Physician profile
Patrick Donovan Walker
NPI 1750352233
$21,280.89
in general payments reported to CMS, 2019-2025
7 companies · $19.55 in 2025
The $19.55 reported for 2025 was less than what a typical Anatomic Pathology provider received nationally (typical 2025 total: $110).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,852 · 2020: $3,014 · 2021: $71.80 · 2022: $31.82 · 2023: $37.15 · 2024: $10K · 2025: $19.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,613 · Travel and Lodging: $1,278 · Food and Beverage: $422.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,612.50 |
| Travel and Lodging | $1,277.89 |
| Food and Beverage | $421.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Travere Therapeutics, INC. | $10,791.91 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $10,255.28 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $104.02 | 2019-2022 | |
| Abbott Laboratories | $78.62 | 2021-2023 | Freestyle Libre 3 |
| Amgen INC. | $19.55 | 2025 | Krystexxa |
| Abbvie INC. | $16.88 | 2021 | |
| Allergan, INC. | $14.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.